Peijia Medical Limited (HKG:9996)

Peijia Medical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	666.74	795.77	1,670	2,296	2,458
Short-Term Investments	31.04	70	1.87	1.93	2.14
Trading Asset Securities	14.75	77.16	71.56	-	3.26
Cash & Short-Term Investments	712.52	942.93	1,743	2,298	2,464
Cash Growth	-24.44%	-45.91%	-24.15%	-6.72%	373.32%
Accounts Receivable	101.04	80.21	12.6	-	-
Other Receivables	-	-	63.26	31.41	40.6
Receivables	101.04	80.21	75.86	31.41	40.6
Inventory	156.8	170.65	173.19	85.97	35.58
Other Current Assets	16.64	43.71	15.3	10.95	4.32
Total Current Assets	987	1,237	2,007	2,426	2,544
Property, Plant & Equipment	695.76	498.61	327.44	176.22	107.35
Long-Term Investments	326.81	387.06	415.49	224.42	-
Goodwill	51.66	51.66	51.66	51.66	51.66
Other Intangible Assets	574.77	476.22	487.29	224.84	162.06
Long-Term Deferred Charges	29.57	-	-	-	-
Other Long-Term Assets	23.14	20.94	13.33	60.16	16.12
Total Assets	2,689	2,672	3,316	3,164	2,881
Accounts Payable	25.72	19.71	361.58	54.17	8.13
Accrued Expenses	50.65	53	50.48	24.49	14.96
Short-Term Debt	89.78	13.83	56.06	-	-
Current Portion of Leases	2.09	2.59	2.89	3.55	9.13
Current Income Taxes Payable	1.27	-	15.27	5.39	-
Current Unearned Revenue	-	-	-	-	0.71
Other Current Liabilities	273.19	65.12	91.75	31.12	11.47
Total Current Liabilities	442.7	154.25	578.02	118.71	44.39
Long-Term Debt	158.31	203.59	70.77	-	-
Long-Term Leases	3.22	1.13	2.15	4.08	-
Long-Term Unearned Revenue	20.77	13.1	1.72	1.37	3.28
Long-Term Deferred Tax Liabilities	16.78	20.32	20.32	20.32	20.32
Other Long-Term Liabilities	2.32	5.49	5.87	-	-
Total Liabilities	644.11	397.88	678.86	144.48	67.99
Common Stock	0.47	0.48	0.48	0.47	0.45
Additional Paid-In Capital	6,323	6,359	6,369	6,339	5,512
Retained Earnings	-	-	-3,713	-3,305	-2,731
Treasury Stock	-	-	-82.74	-84.55	-23.13
Comprehensive Income & Other	-4,296	-4,085	63.62	69.14	54.41
Total Common Equity	2,028	2,274	2,638	3,019	2,813
Minority Interest	16.56	-0.03	-	-	-
Shareholders' Equity	2,045	2,274	2,638	3,019	2,813
Total Liabilities & Equity	2,689	2,672	3,316	3,164	2,881
Total Debt	253.4	221.14	131.88	7.63	9.13
Net Cash (Debt)	459.12	721.79	1,611	2,290	2,454
Net Cash Growth	-36.39%	-55.20%	-29.65%	-6.68%	-
Net Cash Per Share	0.69	1.06	2.39	3.46	5.26
Filing Date Shares Outstanding	665.19	675.51	672.2	666.69	631.84
Total Common Shares Outstanding	665.19	675.51	672.2	666.69	631.84
Working Capital	544.3	1,083	1,429	2,308	2,500
Book Value Per Share	3.05	3.37	3.92	4.53	4.45
Tangible Book Value	1,402	1,746	2,099	2,743	2,600
Tangible Book Value Per Share	2.11	2.59	3.12	4.11	4.11
Buildings	433.17	61.97	53.56	53.53	53.53
Machinery	184.28	152.79	109.64	76.51	41.48
Construction In Progress	122.31	290.45	167.41	28.61	1.05
Leasehold Improvements	40.72	39.11	38.6	31.06	17.9

Updated Sep 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.